ERCC1 and breast cancer: Therefore, it is essential to explore the molecular mechanisms of multi-drug resistance and the reversal strategy are very important in breast cancer treatment [23-26].One of the mechanisms of tumor resistance to cisplatin is increased NER activity, in particular increased levels of ERCC1, which is a key gene involved in NER of damaged DNA by ultraviolet radiation or chemical agents.